Carmona-Rocha, E, Torné, CD, Alonso, AML, Puig, L. [Translated article] Methotrexate-Induced Gouty Arthritis in Psoriatic Patient. Actas Dermo-Sifiliograficas. 2025; 116(10)DOI:10.1016/j.ad.2025.10.010. PMID:41067613. IF:(Q/D).

Fernández, CPH, Borrego, L, Arnau, AMG, Sánchez, TS, Carrillo, JMC, Ninet, VZ, Baldrich, ES, Miquel, FJM, Salvador, JFS, Guijarro, SC, Gilo, AS, García, PM, Triviño, FN, Romero, FT, Serna, MR, Ninot, GM, González, IR, de la Fuente, EG, Nieto, MAP, Guillén, PSP, Pérez, JS, Rodríguez, JJP, Ortega, MEG, Pérez, RG, Doval, IG, Descalzo, MAG. [Translated article] Should Hydroxyisohexyl 3-Cyclohexene Carboxaldehyde (Lyral®) Still be Part of the Baseline Series?. Actas Dermo-Sifiliograficas. 2025; 116(10)DOI:10.1016/j.ad.2025.10.016. PMID:41076186. IF:(Q/D).

Mateu-Arrom, L, Nogueira, XAV, Puig, L, Spertino, J. Predictors of response to omalizumab and relapse in chronic spontaneous Urticaria: a narrative review focusing on parameters available in routine clinical practice. Frontiers In Allergy. 2025; 6DOI:10.3389/falgy.2025.1688464. PMID:41246132. IF:(Q/D).

Torres, T, Puig, L. Letter to the Editor Regarding: "Cardiovascular and Kidney Outcomes After Systemic Treatment for Plaque Psoriasis: A Systematic Review and Network Meta-Analysis". Dermatology and Therapy. 2025; 15(10)DOI:10.1007/s13555-025-01513-z. PMID:40779225. IF:4.200(Q1/1D).

Pinter, A, Brnabic, A, Trovato, E, Puig, L, Carrascosa, JM, Boye, T, Megna, M, Sabatino, S, de la Torre, I, Maul, JT. Comparative Effectiveness and Durability of Biologics Through 24 Months for Patients with Moderate-to-Severe Psoriasis: Results from the International, Observational Psoriasis Study of Health Outcomes (PSoHO). Dermatology and Therapy. 2025; 15(10)DOI:10.1007/s13555-025-01494-z. PMID:40699538. IF:4.200(Q1/1D).

Bouhatous, YM, Bredrup, C, Maurer, A, Mirakovska, L, Foster, A, Kosaki, K, Jost, C, Demoulin, JB, Luu, M, Vabres, P, Kurtz, JE, Schaefer, E, Guimier, A, Cormier-Daire, V, Lim, D, Thompson, S, Olson, L, Kwon, HR, Aguirre-Rodriguez, C, Hernandez-Dorronsoro, U, Martinez-Soroa, I, Iznardo, H, Mascaro, JMJ, Baselga, E, Kalantari, S, Mussa, A, Gazzin, A, Carli, D, Svinvik, I, Mutlu-Albayrak, H, Bluefeather, S, Zarate, Y, Takenouchi, T, Naicker, T, Chateau, A, Gokhul, A, Dube-Pule, A, Haniffa, M, Peitee, WO, Nordgren, A, Carpentier, M, Binquet, C, Briffaut, AS, Bal, L, Pond, D, Rustad, CF, Bardou, M, Faivre, L. 'Knowing and Treating Kosaki/Penttinen syndrome' international collaborative consortium: recommendations for follow-up, natural history and a real-life observational study about safety and efficacy profile of tyrosine kinase inhibitors. JOURNAL OF MEDICAL GENETICS. 2025; 62(10)DOI:10.1136/jmg-2024-110600. PMID:40707250. IF:3.700(Q2/3D).